Efficacy and Safety of Checkpoint Inhibitor Treatment in Patients with Advanced Renal or Urothelial Cell Carcinoma and Concomitant Chronic Kidney Disease: A Retrospective Cohort Study

SIMPLE SUMMARY: Immune checkpoint inhibition plays a pivotal role in the treatment of metastatic renal cell carcinoma and metastatic urothelial carcinoma. The association of chronic kidney disease with these tumors is well established. However, to what extent kidney failure modifies the efficacy or...

Descripción completa

Detalles Bibliográficos
Autores principales: Seydel, Florian, Delecluse, Susanne, Zeier, Martin, Holland-Letz, Tim, Haag, Georg Martin, Berger, Anne Katrin, Grün, Barbara Christine, Bougatf, Nina, Hohenfellner, Markus, Duensing, Stefan, Jäger, Dirk, Zschäbitz, Stefanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036307/
https://www.ncbi.nlm.nih.gov/pubmed/33915693
http://dx.doi.org/10.3390/cancers13071623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036307/
https://www.ncbi.nlm.nih.gov/pubmed/33915693
http://dx.doi.org/10.3390/cancers13071623

Ejemplares similares